Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules-Reference-Cited by-同舟云学术

Pharmacophore based virtual screening, molecular docking and molecular dynamic simulation studies for finding ROS1 kinase inhibitors as potential drug molecules

Published:2020-11-17 Issue: Volume: Page:1-15
ISSN:0739-1102
Container-title:Journal of Biomolecular Structure and Dynamics
language:en
Short-container-title:Journal of Biomolecular Structure and Dynamics

Author:

Vanajothi Ramar¹,Vedagiri Hemamalini²,Al-Ansari Mysoon M.³,Al-Humaid Latifah A.³,Kumpati Premkumar¹

Affiliation:

1. Department of Biomedical Science, Bharathidasan University, Tamil Nadu, India

2. Department of Bioinformatics, Bharathiar University, Coimbatore, India

3. Department of Botany and Microbiology, College of Science King Saud University, Riyadh, Saudi Arabia

Publisher

Informa UK Limited

Subject

Molecular Biology,General Medicine,Structural Biology

Link

https://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1847195

Reference48 articles.

1. Acquired Resistance to Crizotinib from a Mutation in CD74–ROS1

2. ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers

3. A Novel Crizotinib-Resistant Solvent-Front Mutation Responsive to Cabozantinib Therapy in a Patient with ROS1-Rearranged Lung Cancer

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. New insight on antioxidants and anti-obesity properties of two seagrasses Thalassia hemprichii and Zostera marina: an integrated molecular docking simulation with in vitro study;F1000Research;2024-04-08

2. Identification of potent allosteric inhibitors of PRMT3: pharmacophore based 3D-QSAR modeling and molecular simulations approach;2023-11-08

3. New insight on antioxidants and anti-obesity properties of two Indonesian seagrass Thalassia hemprichii and Zostera marina: an integrated molecular docking simulation with in vitro study;F1000Research;2023-06-21

4. Clinical Relevance of Targeted Therapy and Immune-Checkpoint Inhibition in Lung Cancer;Pharmaceutics;2023-04-16

5. Identification of Flavonoids as Putative ROS-1 Kinase Inhibitors Using Pharmacophore Modeling for NSCLC Therapeutics;Molecules;2021-04-07